FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:497-500 July 29, 2004 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Kriege, M. PubMed Citation

More than 275,000 women in the United States will receive a diagnosis of breast cancer this year, and 40,110 women will die of the disease.¹ Randomized trials have shown that the use of screening mammography in the general population reduces mortality associated with breast cancer by at least 24 percent.² Cancer is detected in 5 to 7 of every 1000 women on the first screening mammogram and in 2 or 3 of every 1000 women who undergo regular screening mammography. Although the average lifetime risk of breast cancer in an American woman is one in seven,¹ the risk increases in . . . [Full Text of this Article]

Source Information

From the Memorial Sloan-Kettering Cancer Center, New York.

This article has been cited by other articles:

• Baron, R. J. (2007). Quality Improvement with an Electronic Health Record: Achievable, but Not Automatic. ANN INTERN MED 147: 549-552 [Abstract] [Full Text]  
• Bartella, L., Huang, W. (2007). Proton (1H) MR Spectroscopy of the Breast. RadioGraphics 27: S241-S252 [Abstract] [Full Text]  
• Schoder, H., Gonen, M. (2007). Screening for Cancer with PET and PET/CT: Potential and Limitations. JNM 48: 4S-18S [Abstract] [Full Text]  
• Bartella, L., Morris, E. A., Dershaw, D. D., Liberman, L., Thakur, S. B., Moskowitz, C., Guido, J., Huang, W. (2006). Proton MR Spectroscopy with Choline Peak as Malignancy Marker Improves Positive Predictive Value for Breast Cancer Diagnosis: Preliminary Study. Radiology 239: 686-692 [Abstract] [Full Text]  
• Irwig, L., Houssami, N., Armstrong, B., Glasziou, P. (2006). Evaluating new screening tests for breast cancer.. BMJ 332: 678-679 [Full Text]  
• Wolbarst, A. B., Hendee, W. R. (2006). Evolving and Experimental Technologies in Medical Imaging. Radiology 238: 16-39 [Abstract] [Full Text]  
• Crandall, C., Pregler, J. P. (2005). Update in Women's Health. ANN INTERN MED 143: 823-829 [Full Text]  
• Liberman, L., Bracero, N., Morris, E., Thornton, C., Dershaw, D. D. (2005). MRI-Guided 9-Gauge Vacuum-Assisted Breast Biopsy: Initial Clinical Experience. Am. J. Roentgenol. 185: 183-193 [Abstract] [Full Text]  
• Sardanelli, F., Podo, F., Philpotts, L. E. (2005). Women with History of Breast Cancer Excluded from Screening Programs: Is It the Right Choice? * Dr Philpotts responds:. Radiology 234: 971-972 [Full Text]  
• Robson, M. E., Offit, K. (2004). Breast MRI for Women With Hereditary Cancer Risk. JAMA 292: 1368-1370 [Full Text]  
• (2004). Breast Cancer Screening in High-Risk Women: Does MRI Add Value?. JWatch Women's Health 2004: 1-1 [Full Text]  
• (2004). Breast Cancer Screening by MRI in High-Risk Women. JWatch Gastroenterology 2004: 9-9 [Full Text]  
• (2004). Breast Cancer Screening by MRI in High-Risk Women. JWatch General 2004: 4-4 [Full Text]